The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice

RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?

(2017) Shi Du Yan et al.   JOURNAL OF ALZHEIMERS DISEASE

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer’s disease

(2015) Douglas Walker et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis

(2015) Jonathan Wall et al.   MOLECULES

Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: A positive role for peptide dehalogenation

(2014) Emily B. Martin et al.   PEPTIDES

New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy

(2014) Satoshi Saito et al.   Frontiers in Aging Neuroscience

Stable RAGE-Heparan Sulfate Complexes Are Essential for Signal Transduction

(2013) Ding Xu et al.   ACS Chemical Biology

Systemic Amyloidoses

(2013) Luis M. Blancas-Mejía et al.   Annual Review of Biochemistry

A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo

(2013) Jonathan S. Wall et al.   PLoS One

Synthesis and structure–activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer’s disease

(2012) Yun Suk Lee et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils

(2012) Jonathan S. Wall et al.   PLoS One

Pattern Recognition with a Fibril-Specific Antibody Fragment Reveals the Surface Variability of Natural Amyloid Fibrils

(2011) Christian Haupt et al.   JOURNAL OF MOLECULAR BIOLOGY

Comparative Analysis of Peptide p5 and Serum Amyloid P Component for Imaging AA Amyloid in Mice Using Dual-Isotope SPECT

(2011) Jonathan S. Wall et al.   MOLECULAR IMAGING AND BIOLOGY

SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies

(2011) Jonathan S. Wall et al.   NUCLEAR MEDICINE AND BIOLOGY

In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides

(2011) J. S. Wall et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease

(2010) Marwan N. Sabbagh et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging

(2010) Shi Fang Yan et al.   BIOCHEMICAL PHARMACOLOGY

The Heparan Sulfate Motif (GlcNS6S-IdoA2S)3, Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and Disease

(2010) Nicole C. Smits et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Amyloid Fibril Recognition with the Conformational B10 Antibody Fragment Depends on Electrostatic Interactions

(2010) Christian Haupt et al.   JOURNAL OF MOLECULAR BIOLOGY

Structural Basis for Ligand Recognition and Activation of RAGE

(2010) Michael Koch et al.   STRUCTURE

Importance of the spatial display of charged residues in heparin–peptide interactions

(2009) Anthony Rullo et al.   BIOPOLYMERS

RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer’s disease

(2009) Fang Fang et al.   FASEB JOURNAL

Soluble forms of RAGE in internal medicine

(2009) Natale Vazzana et al.   Internal and Emergency Medicine

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation

(2009) Louis J Sparvero et al.   Journal of Translational Medicine

Natural Protective Amyloids

(2008) Vassiliki Iconomidou et al.   CURRENT PROTEIN & PEPTIDE SCIENCE